KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Other Accumulated Expenses (2016 - 2025)

West Pharmaceutical Services' Other Accumulated Expenses history spans 17 years, with the latest figure at $213.1 million for Q3 2025.

  • For Q3 2025, Other Accumulated Expenses rose 33.77% year-over-year to $213.1 million; the TTM value through Sep 2025 reached $213.1 million, up 33.77%, while the annual FY2024 figure was $188.2 million, 21.26% up from the prior year.
  • Other Accumulated Expenses for Q3 2025 was $213.1 million at West Pharmaceutical Services, down from $222.8 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $222.8 million in Q2 2025 and bottomed at $2.3 million in Q3 2022.
  • The 5-year median for Other Accumulated Expenses is $159.3 million (2024), against an average of $129.1 million.
  • The largest annual shift saw Other Accumulated Expenses plummeted 97.5% in 2021 before it surged 7558.33% in 2022.
  • A 5-year view of Other Accumulated Expenses shows it stood at $2.4 million in 2021, then soared by 7558.33% to $183.8 million in 2022, then fell by 15.56% to $155.2 million in 2023, then increased by 21.26% to $188.2 million in 2024, then increased by 13.23% to $213.1 million in 2025.
  • Per Business Quant, the three most recent readings for WST's Other Accumulated Expenses are $213.1 million (Q3 2025), $222.8 million (Q2 2025), and $186.4 million (Q1 2025).